TITLE

Vascular consequences of menopause and hormone therapy: Importance of timing of treatment and type of estrogen

AUTHOR(S)
Dubey, Raghvendra K.; Imthurn, Bruno; Barton, Matthias; Jackson, Edwin K.
PUB. DATE
May 2005
SOURCE
Cardiovascular Research;May2005, Vol. 66 Issue 2, p295
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract: Premenopausal women have a lower risk for cardiovascular events, and mortality due to coronary vascular disease (CVD) in premenopausal women is rare. These facts suggest that endogenous estrogens, such as estradiol, protect the cardiovascular system, and several observational studies and a few small clinical studies conducted in healthy and younger postmenopausal women support this hypothesis. In contrast, two large randomized clinical trials (RCTs), using conjugated equine estrogens and conducted in older women with established CVD or without overt CVD, failed to demonstrate protection against CVD by exogenous estrogens. These divergent findings have resulted in confusion with regard to the association between estrogen deficiency and CVD in postmenopausal women. In order to reconcile these contradictory findings, it is necessary to examine the pathophysiology associated with age-dependent changes within the vessel wall and to compare the pharmacology of different types of estrogens. Understanding age-dependent changes in vascular pathology and the pharmacology of different estrogens may facilitate the development of therapeutic strategies for hormone replacement therapy (HRT) that would be effective in delaying vascular remodeling leading to CVD following menopause. In this review we provide an overview of the impact of menopause and estrogen deficiency on vascular remodeling and emphasize the importance of timing and type of estrogen to achieve maximum benefits with regard to reducing the risk of CVD.
ACCESSION #
17639338

 

Related Articles

  • Hormone Replacement Therapy: The Need for Reconsideration. Rosenberg, Lynn // American Journal of Public Health;Dec1993, Vol. 83 Issue 12, p1670 

    Millions of menopausal women are taking hormone supplements. Observational studies suggest that unopposed estrogens reduce the risk of cardiovascular disease and fractures and increase the risk of endometrial cancer and, possibly, breast cancer. In the absence of information from randomized...

  • Chapter 10: Menopause, Power, and Heat. Martin, Emily // Woman in the Body;2001, p166 

    Chapter 10 of the book "The Woman in the Body" is presented. It examines whether there is an alternative cultural grammar of menopause despite its public image of atrophy and failure. It discusses hot flashes, the one true physical indication specific to menopause. Researchers on menopause...

  • GIVING MENOPAUSE ITS PROPER PLACE. Hays, Bethany // Integrative Medicine: A Clinician's Journal;Oct/Nov2006, Vol. 5 Issue 5, p32 

    The article focuses on the hormonal complications involved in the problem of menopause faced by women. Feasibility of the hormone replacement therapy in this context is discussed. It reveals that besides estrogen, adrenaline and cortisol hormones should also be dealt with during the problem. Hot...

  • Adiposity and Reporting of Vasomotor Symptoms among Midlife Women: The Study of Womens Health Across the Nation. Rebecca C. Thurston; MaryFran R. Sowers; Yuefang Chang; Barbara Sternfeld; Ellen B. Gold; Janet M. Johnston; Karen A. Matthews // American Journal of Epidemiology;Jan2008, Vol. 167 Issue 1, p78 

    It has long been hypothesized that increased adiposity would be associated with decreased vasomotor symptoms during menopause because of conversion of androgens to estrogens in body fat. However, recent thermoregulatory models have postulated that increased adipose tissue would be associated...

  • Reproductive History and Risk of Colorectal Cancer in Postmenopausal Women. Zervoudakis, Alice; Strickler, Howard D.; Yikyung Park; Xiaonan Xue; Hollenbeck, Albert; Schatzkin, Arthur; Gunter, Marc J. // JNCI: Journal of the National Cancer Institute;May2011, Vol. 103 Issue 10, p826 

    Background There are conflicting data regarding the role of sex hormones in colorectal cancer development. Whereas clinical trials data indicate that hormone therapy use reduces the risk of colorectal cancer, data from prospective cohort studies suggest that circulating estrogen levels are...

  • Efficacy of pulsed estrogen therapy in relatively younger patients with surgically induced menopause. N. Yesildaglar; S. Erkaya; D. Uygur; K. Göl; B. Bingöl; Z. Günenç // Human Reproduction;Jan2004, Vol. 19 Issue 1, p210 

    BACKGROUND: Pulsed estrogen therapy is a new approach in estrogen replacement therapy. We carried out a prospective study to evaluate the efficacy of pulsed estrogen therapy in relatively younger patients with surgically induced menopause. METHODS: Patients (n = 138) <45 years old and suffering...

  • Menopause: not just ovarian failure.  // Contemporary OB/GYN;Apr2005, Vol. 50 Issue 4, p14 

    Discusses research being done on the correlation between hypothalamic-pituitary insensitivity to estrogen and menopause. Reference to a study by G. Weiss et al., published in a 2004 issue of the "Journal of the American Medical Association"; Study procedure; Study findings.

  • The Aging Ovary. Shifren, Jan L.; Schiff, Isaac // Journal of Women's Health & Gender-Based Medicine;Jan2000 Supplement 1, Vol. 9 Issue 1, p3 

    During reproductive life, ovarian steroid biosynthesis is gonadotropin dependent and occurs in theca and granulosa cells. In the menopausal ovary, there is atresia of ovarian follicles, with sparing of the androgen-producing theca-interstitial cell component. The aging ovary, therefore, produces...

  • Monophasic Estrogen-Progestogen Therapy and Sexuality in Postmenopausal Women. Fonseca, A. M.; Bagnoli, V. R.; Penteado, S. R. L.; Paixão, J. S.; Cavalcanti, A. L.; Pinotti, J. A. // Clinical Drug Investigation;2007, Vol. 27 Issue 2, p131 

    OBJECTIVE: This study aimed to evaluate the effects of monophasic estrogen-progestogen therapy on the sexuality and climacteric symptoms of postmenopausal women. PATIENTS AND METHODS: A prospective, randomised, double-blind, crossover, placebo-controlled, single-centre study was carried out...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics